Skip to content

Effectiveness of Shock Wave Therapy for Upper Limb Spasticity

Effectiveness of Shock Wave Therapy to Treat Upper Limb Spasticity in Hemiparetic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04316026
Enrollment
48
Registered
2020-03-20
Start date
2019-09-02
Completion date
2024-06-30
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Introduction: Shock wave therapy (SWT) has a potential interest to treat spasticity. However, the pathophysiology of this treatment remains unknown. Some authors assert that it is effective on spasticity itself, while others suggest that it acts more on fibrosis. Method: this study will assess the effectiveness of radial SWT to treat wrist and finger flexors stiffness in stroke patients, comparing subacute spastic patients (\< 12 months) with chronic patients presenting muscle contractures (\> 12 months). Forty-eight stroke patients (24 in the subacute phase and 24 in the chronic phase) will be included. One real and one sham sessions of SWT will be performed with a 2-week interval. The order of the sessions will be randomized. Motor control, stiffness and spasticity will be assessed with clinical and objective measures, just after and just before each session, by a blind assessor. The targeted muscles will be flexor carpi radialis, flexor carpi ulnaris and flexor digitorum profundus, and will be the same for the two session.

Interventions

DEVICEshock wave therapy

Shockwave therapy is a non-invasive treatment creating a series of low energy acoustic wave pulsations that are directly applied through the skin via a gel medium

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* History of cerebral lesion * Wrist spasticity ≥ 1+/4 on the Modified Ashworth Scale * Wrist spasticity ≥ 2/4 on the Tardieu Scale * Passive dorsal extension of the wrist ≥ 10°

Exclusion criteria

* Botulinum toxin injection in the upper limb in the past three months * History of wrist arthrodesis * Myopathy * Treatment with oral anticoagulants or coagulation disease * Tumor or infection of the paretic upper limb

Design outcomes

Primary

MeasureTime frameDescription
Modified Ashworth ScaleBefore (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)Clinical assessment of spasticity for wrist and fingers flexors, score from 0 to 4 (a higher score representing a greater spasticity)
Tardieu scaleBefore (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)Clinical assessment of spasticity for wrist and fingers flexors; score from 0 to 4 (a higher score representing a greater spasticity)

Secondary

MeasureTime frameDescription
objective measure of elastic and viscous stiffness of the wrist, expressed in N.m.radBefore (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)electronic oscillatory device for stiffness measurement
objective measure of muscle stiffnessBefore (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)Myoton measurement device
manual goniometerBefore (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)Passive measure of joint range of motion
Medical Research Council muscle testingBefore (baseline) and 25 minutes (post-treatment) after each of the two sessions (sham or real SWT)strength assessment; score from 0 to 5 (a higher score representing a greater strength)
Isokinetic dynamometerBefore (baseline) and 15 minutes (post-treatment) after each of the two sessions (sham or real SWT)objective measure of muscle stiffness at the wrist
H reflexBefore (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)electrophysiological assessment of the H reflex (motoneuronal excitability)
Box and block testBefore (baseline) and 30 minutes (post-treatment) after each of the two sessions (sham or real SWT)measure of manual ability
Fugl Meyer Assessment - computerized adaptive testingBefore (baseline) and 25 minutes (post-treatment) after each of the two sessions (sham or real SWT)neurological impairment
Abilhand scaleBefore (baseline) and 45 minutes (post-treatment) after each of the two sessions (sham or real SWT)PROMS on bimanual activities; a higher score represents a better manual ability
Wolff Motor Function TestBefore (baseline) and 35 minutes (post-treatment) after each of the two sessions (sham or real SWT)manual activities
Visual Analog ScaleBefore (baseline) and 45 minutes (post-treatment) after each of the two sessions (sham or real SWT)patient self-assessment of overall effectiveness of SWT; score from 0 to 4 (a higher score representing a greater improvement)

Countries

Belgium

Contacts

Primary ContactGaëtan Stoquart, MD PhD
gaetan.stoquart@uclouvain.be+3227641650
Backup ContactClara Selves, MD
clara.selves@uclouvain.be+3227641650

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026